SMAD7 and metabolic dysfunction-associated steatohepatitis: The livers of NASH patients as well as a mouse model of NASH exhibit increased nuclear localization of the SMAD2/3/4 complex and the reduced expression of SMAD7, which all together contribute to increased TGFβ, Co1α1, and αSMA [42].